Overview

Extension Study to PTR-01-002

Status:
Not yet recruiting
Trial end date:
2022-09-30
Target enrollment:
Participant gender:
Summary
A sub-set of patients who participated in PTR-01-002 will be enrolled in an open-label study, if they meet the study eligibility criteria.
Phase:
Phase 2
Details
Lead Sponsor:
Phoenix Tissue Repair, Inc.
Collaborator:
Phoenix Tissue Repair, a BridgeBio company